The range of oxygenation in SiHa tumor xenografts

Radiation Research

Volumn 158, Issue 2, 2002, Pages 159-166

  Olive, Peggy L ^a   Banáth, Judit P ^a   Durand, Ralph E ^a  

^a BRITISH COLUMBIA CANCER RESEARCH CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

1 (2 BROMOETHYLAMINO) 3 (2 NITRO 1 IMIDAZOLYL) 2 PROPANOL; 1 AZIRIDINO 3 (2 NITRO 1 IMIDAZOLYL) 2 PROPANOL; CELL DNA; PIMONIDAZOLE; 1-(2-NITRO-1-IMIDAZOLYL)-3-AZIRIDINO-2-PROPANOL; DRUG DERIVATIVE; MISONIDAZOLE; NITROIMIDAZOLE DERIVATIVE; RADIOSENSITIZING AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL DESTRUCTION; CANCER RADIOTHERAPY; CELL HYPOXIA; CELL KILLING; CONTROLLED STUDY; DNA CROSS LINKING; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; RADIOSENSITIVITY; TISSUE OXYGENATION; TUMOR XENOGRAFT; UTERINE CERVIX CARCINOMA; ANIMAL; CARCINOMA; CELL SURVIVAL; COMET ASSAY; DNA DAMAGE; DRUG EFFECT; FEMALE; IN VITRO STUDY; METABOLISM; MOUSE MUTANT; NONOBESE DIABETIC MOUSE; OXYGEN CONSUMPTION; PATHOLOGY; RADIATION EXPOSURE; UTERINE CERVIX TUMOR; XENOGRAFT;

ANIMALS; CARCINOMA; CELL SURVIVAL; COMET ASSAY; DNA DAMAGE; FEMALE; HUMANS; MICE; MICE, INBRED NOD; MICE, SCID; MISONIDAZOLE; NITROIMIDAZOLES; OXYGEN CONSUMPTION; RADIATION-SENSITIZING AGENTS; TRANSPLANTATION, HETEROLOGOUS; UTERINE CERVICAL NEOPLASMS;

EID: 0036022343     PISSN: 00337587     EISSN: None     Source Type: Journal    
DOI: 10.1667/0033-7587(2002)158[0159:TROOIS]2.0.CO;2     Document Type: Article

References (44)

1. Oxygenation predicts radiation response and survival in patients with cervix cancer
2. Definitive evidence for hypoxic cells influencing cure in cancer therapy
3. Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix
4. Pretreatment oxygenation predicts radiation response in advanced squamous cell carcinoma of the head and neck
5. Oxygen delivery: Implications for the biology and therapy of solid tumors
6. Tumour hypoxia: The picture has changed in the 1990s
7. Respiration-induced oxygen gradients in cultured mammalian cells
8. A multicomponent x-ray survival curve for mouse lymphosarcoma cells irradiated in vivo
9. Radiation-induced reoxygenation in the SCCVII murine tumour: Evidence for a decrease in oxygen consumption and an increase in tumour perfusion
10. Fluorescence immunohistochemical detection of hypoxic cells in spheroids and tumours
11. Biodistribution of the nitroimidazole EF5 (2-[2-nitro-1H-imidazol-1-yl]-N-(2,2,3,3,3-pentafluoropropyl) acetamide) in mice bearing subcutaneous EMT6 tumors
12. Detection of hypoxic cells by monoclonal antibody recognizing 2-nitroimidazole adducts
13. Evaluation of the concept of "hypoxic fraction" as a descriptor of tumor oxygenation status
14. Cells at intermediate oxygen levels can be more important than the "hypoxic fraction" in determining tumor response to fractionated radiotherapy
15. Proliferation and hypoxia in human squamous cell carcinoma of the cervix: First report of combined immunohistochemical assays
16. 3H-misonidazole to solid human tumors as a measure of tumor hypoxia
17. Radiobiological and imnmnohistochemical assessment of hypoxia in human melanoma xenografts: Acute and chronic hypoxia in individual tumours
18. Intermittent blood flow in a murine tumor: Radiobiological effects
19. Evidence for acutely hypoxic cells in mouse tumours and a possible mechanism for reoxygenation
20. Acute hypoxia in tumors: Implications for modifiers of radiation effects
21. Fluctuations in red cell flux in tumor microvessels can lead to transient hypoxia and reoxygenation in tumor parenchyma
22. Concepts of oxygen transport at the microcirculatory level
23. Microregional fluctuations in perfusion within human tumours detected using laser Doppler flowmetry
24. Vascular architecture and hypoxic profiles in human head and neck squamous cell carcinomas
25. Inducible repair and the two forms of tumour hypoxia - Time for a paradigm shift
26. Perivascular oxygen tensions in a transplantable mammary tumor growing in a dorsal flap window chamber
27. 2 gradients in solid tumors in vivo: High-resolution measurements reveal a lack of correlation
28. RSU 1069, a 2-nitroimidazole containing an alkylating group: High efficiency as a radio- and chemosensitizer in vitro and in vivo
29. RSU 1069, a nitroimidazole containing an aziridine group. Bioreduction greatly increases cytotoxicity under hypoxic conditions
30. Induction of DNA crosslinks in vitro upon reduction of the nitroimidazole-aziridines RSU-1069 and RSU-1131
31. Detection of hypoxia by measurement of DNA damage in individual cells from spheroids and murine tumours exposed to bioreductive drugs. II. RSU 1069
32. Targeting gene expression to hypoxic tumor cells
33. Oxygen diffusion and oxygen depletion problems in radiobiology
34. Identification of nonproliferating but viable hypoxic tumor cells in vivo
35. Comparison between the comet assay and pimonidazole binding for measuring tumour hypoxia
36. Comparisons among pimonidazole binding, oxygen electrode measurements, and radiation response in C3H mouse tumors
37. Comparison between the comet assay and pimonidazole binding for measuring tumor hypoxia
38. Unusual oxygen concentration dependence of toxicity of SR-4233, a hypoxic cell toxin
39. Estimation of oxygen distribution in RIF-1 tumors by diffusion model-based interpretation of pimonidazole hypoxia and Eppendorf measurements
40. Evidence that hypoxia markers detect oxygen gradients in liver: Pimonidazole and retrograde perfusion of rat liver
41. The lifetime of hypoxic human tumor cells
42. Possible mechanisms for intermittent blood flow in the murine SCCVII carcinoma
43. The use of fluorescent probes to identify regions of transient perfusion in murine tumors
44. Contribution of transient blood flow to tumour hypoxia in mice